DUBLIN--(BUSINESS WIRE)--Feb. 2, 2016--
Alkermes
plc (NASDAQ: ALKS) announced today that its corporate presentation
will be webcast live at the 18th Annual BIO CEO & Investor
Conference on Tuesday, Feb. 9, 2016, at 3:00 p.m. EST (8:00 p.m. GMT)
from the Waldorf Astoria Hotel in New York City. In addition, Alkermes
will webcast a live fireside chat, featuring Richard Pops, at the
Leerink 2016 Global Healthcare Conference on Thursday, Feb. 11, 2016, at
12:00 p.m. EST (5:00 p.m. GMT), also from the Waldorf Astoria Hotel in
New York City. These presentations may be accessed under the Investors
tab on www.alkermes.com
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
developing innovative medicines for the treatment of central nervous
system (CNS) diseases. The company has a diversified commercial product
portfolio and a substantial clinical pipeline of product candidates for
chronic diseases that include schizophrenia, depression, addiction and
multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has
an R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more information, please visit Alkermes’ website
at www.alkermes.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160202006528/en/
Source: Alkermes plc
Alkermes plc
Eva Stroynowski, +1 781 609 6823
Corporate
Communications